Eric J Stanbridge
Overview
Explore the profile of Eric J Stanbridge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abd-Aziz N, Stanbridge E, Shafee N
J Gen Virol
. 2016 Dec;
97(12):3174-3182.
PMID: 27902314
Newcastle disease virus (NDV) is a candidate agent for oncolytic virotherapy. Despite its potential, the exact mechanism of its oncolysis is still not known. Recently, we reported that NDV exhibited...
2.
Abd-Aziz N, Stanbridge E, Shafee N
Oncol Lett
. 2015 Dec;
10(4):2192-2196.
PMID: 26622817
Bortezomib is the first proteasomal inhibitor (PI) to be used therapeutically for treating relapse cases of multiple myeloma and mantle cell lymphoma. A proposed mechanism for its action is that...
3.
Chng W, Abd-Aziz N, Ong M, Stanbridge E, Shafee N
Cell Oncol (Dordr)
. 2015 May;
38(4):279-88.
PMID: 25930675
Purpose: Newcastle disease virus (NDV) is an oncolytic virus that is known to have a higher preference to cancer cells than to normal cells. It has been proposed that this...
4.
Chng W, Stanbridge E, Yusoff K, Shafee N
J Interferon Cytokine Res
. 2013 Mar;
33(7):346-54.
PMID: 23506478
Viral-mediated oncolysis is a promising cancer therapeutic approach offering an increased efficacy with less toxicity than the current therapies. The complexity of solid tumor microenvironments includes regions of hypoxia. In...
5.
Carter R, Kang L, Darcy K, Kauderer J, Liao S, Rodgers W, et al.
Cancer Causes Control
. 2012 Oct;
23(12):2013-21.
PMID: 23073789
Purpose: In the absence of gold standard diagnoses, we estimate age-specific false-positive and false-negative prediction rates of HPV-, cytology-, and histology-based tests for significant cervical lesions (SCL) in US women...
6.
Liew S, Stanbridge E, Yusoff K, Shafee N
J Ethnopharmacol
. 2012 Oct;
144(2):453-6.
PMID: 23022321
Ethnopharmacological Relevance: Microenvironmental conditions contribute towards varying cellular responses to plant extract treatments. Hypoxic cancer cells are known to be resistant to radio- and chemo-therapy. New therapeutic strategies specifically targeting...
7.
Chng W, Stanbridge E, Wong K, Ong K, Yusoff K, Shafee N
Virol J
. 2012 Aug;
9:155.
PMID: 22877087
Enterovirus 71 (EV71) causes severe neurological diseases resulting in high mortality in young children worldwide. Development of an effective vaccine against EV71 infection is hampered by the lack of appropriate...
8.
Chen H, Ko J, Wong V, Hyytiainen M, Keski-Oja J, Chua D, et al.
Cancer Lett
. 2012 Jun;
325(1):89-98.
PMID: 22743615
This study identified LTBP-2 as a pleiotropic tumor suppressor in nasopharyngeal carcinoma, which safeguards against critical malignant behaviors of tumor cells. LTBP-2 expression was significantly decreased or lost in up...
9.
Lung H, Cheung A, Ko J, Cheng Y, Stanbridge E, Lung M
Semin Cancer Biol
. 2011 Dec;
22(2):87-95.
PMID: 22154888
The identification of cancer genes in sporadic cancers has been recognized as a major challenge in the field. It is clear that deletion mapping, genomic sequencing, comparative genomic hybridization, or...
10.
Lo P, Ko J, Yu Z, Law S, Wang L, Li J, et al.
Cancer Lett
. 2011 Dec;
316(1):39-45.
PMID: 22154084
The group 2 LIM domain protein, Cysteine-rich intestinal protein 2 (CRIP2) was found to play an important role in esophageal squamous cell carcinoma (ESCC) tumorigenesis. Subcellular fractionation studies show that...